Very recently, Chikusetsu saponin IVa was used to alleviate SEVO-induced neuroinflammation and cognitive impairment by blocking NLRP3, likely through reducing apoptosis of neuronal cells (Shao et al., 2020). Here, NLRP3 is linked to Cognitive impairment.